ANIXA BIOSCIENCES ($ANIX) posted quarterly earnings results for Q1 2026 on Monday, March 9th. The company reported earnings of -$0.08 per share, beating estimates of -$0.10 by $0.02. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ANIX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ANIXA BIOSCIENCES Insider Trading Activity
ANIXA BIOSCIENCES insiders have traded $ANIX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ANIX stock by insiders over the last 6 months:
- ARNOLD M BASKIES purchased 10,000 shares for an estimated $30,400
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ANIXA BIOSCIENCES Hedge Fund Activity
We have seen 32 institutional investors add shares of ANIXA BIOSCIENCES stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF AMERICA CORP /DE/ removed 208,382 shares (-97.4%) from their portfolio in Q4 2025, for an estimated $650,151
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 171,687 shares (+213.6%) to their portfolio in Q4 2025, for an estimated $535,663
- MISSION WEALTH MANAGEMENT, LP removed 149,252 shares (-41.9%) from their portfolio in Q4 2025, for an estimated $465,666
- 683 CAPITAL MANAGEMENT, LLC added 113,636 shares (+inf%) to their portfolio in Q4 2025, for an estimated $354,544
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 93,931 shares (+inf%) to their portfolio in Q4 2025, for an estimated $293,064
- D.A. DAVIDSON & CO. removed 75,000 shares (-12.2%) from their portfolio in Q4 2025, for an estimated $234,000
- CITADEL ADVISORS LLC removed 66,318 shares (-69.1%) from their portfolio in Q4 2025, for an estimated $206,912
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ANIXA BIOSCIENCES Analyst Ratings
Wall Street analysts have issued reports on $ANIX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 12/12/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/11/2025
To track analyst ratings and price targets for ANIXA BIOSCIENCES, check out Quiver Quantitative's $ANIX forecast page.
ANIXA BIOSCIENCES Price Targets
Multiple analysts have issued price targets for $ANIX recently. We have seen 2 analysts offer price targets for $ANIX in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $10.0 on 02/04/2026
- Yi Chen from HC Wainwright & Co. set a target price of $7.0 on 09/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
